Cas 1111802-41-5,N'-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidine-2,4-diamine

1111802-41-5

Post Buying Request

Basic information

Product Name: N'-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidine-2,4-diamine
Synonyms: N'-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidine-2,4-diamine
CAS NO:1111802-41-5
Molecular Formula:
Molecular Weight: 435.486
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N'-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidine-2,4-diamine(CAS DataBase Reference)
NIST Chemistry Reference: N'-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidine-2,4-diamine(1111802-41-5)
EPA Substance Registry System: N'-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidine-2,4-diamine(1111802-41-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1111802-41-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1111802-41-5 Suppliers

Recommended suppliers

1111802-41-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1111802-41-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,1,8,0 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1111802-41:
(9*1)+(8*1)+(7*1)+(6*1)+(5*8)+(4*0)+(3*2)+(2*4)+(1*1)=85
85 % 10 = 5
So 1111802-41-5 is a valid CAS Registry Number.

1111802-41-5Upstream product

1111802-41-5Downstream Products

1111802-41-5Relevant academic research and scientific papers

PYRIMIDINE COMPOUNDS HAVING A FGFR INHIBITORY EFFECT

-

Page/Page column 49, (2009/04/25)

There is provided pyrimidine compounds of formula (I): or pharmaceutical salts thereof. There is also provided processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by a FGFR inhibitory effect.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1111802-41-5